EP2822577
Prótín raðbrigðaþáttar VIII
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
15.2.2013EP published:
6.2.2019EP application number:
13749382.1
EP translation filed:
28.2.2019Grant published:
15.3.2019EPO information:
European Patent Register
Max expiry date:
14.2.2033Expiry date:
14.2.2020
Title:
RECOMBINANT FACTOR VIII PROTEINS
Timeline
Today
15.2.2013EP application
6.2.2019EP Publication
28.2.2019Translation submitted
15.3.2019Registration published
14.2.2020Expires
Owner
Name:
Bioverativ Therapeutics Inc.Address:
225 Second Avenue, 02451, Waltham, MA, US
Inventor
Name:
KULMAN, JohnAddress:
Belmont, Massachusetts, US
Agent
Name:
Orsnes PatentAddress:
Sentvedvej 23, DK
Priority
Number:
201261599305 PDate:
15.2.2012Country:
US
Number:
201261670553 PDate:
11.7.2012Country:
US
Number:
201361759785 PDate:
1.2.2013Country:
US
Classification
Categories:
C07K 14/59, C07K 14/755, C07K 14/79, A61K 38/00, A61K 35/14, A61K 38/37
Annual fees
Number
Paid
Expires
Payer
Number: 7
Paid: 15.4.2019
Expires: 14.2.2020
Payer: Guðjón Styrkársson, hrl.